Valuation: genedrive plc

Market Cap 20.87M 27.96M 25.04M 23.04M 39.02M 2.66B 39.75M 275M 110M 1.4B 105M 103M 4.4B P/E 2024
-0.35x
P/E 2025 -1.51x
Enterprise Value 19.69M 26.38M 23.63M 21.73M 36.81M 2.5B 37.5M 259M 104M 1.32B 99M 96.89M 4.16B EV / Sales 2024
7.57x
EV / Sales 2025 7.93x
Free-Float
55.04%
Yield 2024 *
-
Yield 2025 -
1 week-9.30%
Current month-18.75%
1 month-17.02%
6 months+6.56%
Current year+11.43%
1 week 0.94
Extreme 0.945
1.1
1 month 0.94
Extreme 0.945
1.25
Current year 0.75
Extreme 0.75
1.55
1 year 0.7
Extreme 0.7
1.55
3 years 0.19
Extreme 0.19
12.3
5 years 0.19
Extreme 0.19
82
10 years 0.19
Extreme 0.19
302.6
Manager TitleAgeSince
Chief Executive Officer 56 06/08/2024
Director of Finance/CFO 48 07/04/2022
Director TitleAgeSince
Director/Board Member 56 11/09/2023
Director/Board Member 48 07/04/2022
Director/Board Member 57 26/05/2026
Date Insider Type Main position Quantity % Market Cap. Importance
20/12/24 Buy

Chief Financial Officer

1,000,000 0.1841%
20/12/24 Free 400,000 0.0736%
20/12/24 Buy

Chief Executive Officer

1,135,208 0.2090%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-9.30%+31.76%-88.70% 20.93M
-1.72%+3.02%+24.84%+61.56% 262B
-2.00%+1.08%+8.51%+23.61% 167B
-3.73%-2.67%-19.64%+66.81% 156B
-1.66%-8.76%-58.15%-15.23% 61.87B
-2.57%+2.13%+11.27%+49.10% 54.44B
0.00%+2.71%-13.09%-6.48% 53.3B
-3.47%+0.56%+22.12%+70.16% 51.07B
+0.84%-2.97%+9.17%+65.13% 50.25B
-3.61%+1.57%+34.72%+89.05% 47.17B
Average -1.71%+0.59%+5.15%+31.50% 90.26B
Weighted average by Cap. -1.95%+2.44%+4.90%+47.54%

Financials

2024 2025
Net sales 501K 671K 601K 553K 936K 63.73M 954K 6.59M 2.65M 33.52M 2.52M 2.47M 106M 954K 1.28M 1.14M 1.05M 1.78M 121M 1.82M 12.56M 5.04M 63.84M 4.8M 4.69M 201M
Net income -7.08M -9.48M -8.49M -7.81M -13.22M -900M -13.47M -93.12M -37.38M -473M -35.57M -34.81M -1.49B -5.23M -7.01M -6.28M -5.77M -9.78M -665M -9.96M -68.85M -27.64M -350M -26.3M -25.74M -1.1B
Net Debt -5.17M -6.92M -6.2M -5.7M -9.66M -658M -9.84M -68.03M -27.31M -346M -25.99M -25.44M -1.09B -1.18M -1.58M -1.42M -1.3M -2.21M -150M -2.25M -15.56M -6.24M -79.09M -5.94M -5.82M -249M
Projected Income Statement - Annual - genedrive plc
Logo genedrive plc
genedrive plc is a United Kingdom-based pharmacogenetic testing company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need pharmacogenetic platform for the diagnosis of genetic variations. The Company’s products include Genedrive MT-RNR1 ID Kit, Genedrive System, and Genedrive CYP2C19 ID Kit. The Company’s flagship product Genedrive MT-RNR1 ID Kit is a single-use disposable cartridge that circumvents the requirement for cold chain logistics by providing temperature stable reagent test kits for use on their proprietary test platform. The Genedrive System is a rapid thermocycler and signal detection system, enabling PCR and isothermal based amplification techniques. It is a semi- automated system used for qualitative in vitro molecular diagnostic tests. Its Genedrive CYP2C19 ID Kit Molecular point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Employees
43
Date Price Change Volume
31/10/26 GBX 0.9750 0.00% 1,288,163
29/10/26 GBX 0.9750 -2.50% 2,037,284
28/10/26 GBX 1.000 0.00% 2,395,494
27/10/26 GBX 1.000 -2.44% 2,469,561
26/10/26 GBX 1.025 -6.82% 3,640,498

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - genedrive plc